Vaccine Economics and Global Health Equity

This chapter examines the economic aspects of vaccine development with a focus on COVID-19, discussing funding disparities between diseases affecting rich and poor nations. It highlights advancements in therapeutics, including the roles of new drugs and monoclonal antibodies, while emphasizing the necessity for global vaccine access. Additionally, the chapter reflects on personal experiences during lockdown and the evolving business landscape shaped by remote work.